Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
The dopaminergic neuron (A9 subtype) is a large, angular cell type located mainly within the substantia nigra pars compacta. It projects predominantly to dorsal regions of the striatum via the nigrostriatal pathway—a circuit essential for voluntary movement. These cells express markers like TH and GIRK2; they degenerate selectively early during Parkinson's disease progression. Their unique properties make them central both as targets for understanding neurodegeneration mechanisms and as candidates for cell-based restorative therapies aimed at treating PD-related motor deficits.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Dopaminergic Neuron (A9 Subtype) (A9 DA Neuron).